tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yigal Nochomovitz, 99 are a HOLD (19.45%), 391 are a BUY (76.82%), 19 are a SELL (3.73%).
Analyst Yigal Nochomovitz, currently employed at CITI, carries an average stock price target met ratio of 48.9% that have a potential upside of 53.71% achieved within 198 days.
Yigal Nochomovitz’s has documented 1,011 price targets and ratings displayed on 55 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OLMA, Olema Pharmaceuticals at 12-Dec-2025.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 12/24/2015. The price target of $19 was fulfilled within 4 days with a profit of $16.57 (46.58%) receiving and performance score of 116.46.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 29-Aug-2022
$13
3 years 4 months 10 days ago
(29-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold
Since 24-Aug-2022
3 years 4 months 15 days ago
(24-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold
Since 24-Aug-2022
$20
3 years 4 months 15 days ago
(24-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy
Since 19-Mar-2014
$15.25
$27
3 years 4 months 16 days ago
(23-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold
Since 23-Aug-2022
$14
3 years 4 months 16 days ago
(23-Aug-2022)
6/14 (42.86%)
$6.36 (83.25%)
228
Which stock is Yigal Nochomovitz is most bullish on?
Which stock is Yigal Nochomovitz is most reserved on?
What Year was the first public recommendation made by Yigal Nochomovitz?
